Jifa Li
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- RNA modifications and cancer 2
- Oncology 4
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Lehe Yang (8 shared papers)Xiaoying Huang (5 shared papers)Zhiying Deng (2 shared papers)Jichun Tian (2 shared papers)Youqun Xiang (3 shared papers)Chengguang Zhao (3 shared papers)Xuanxuan Dai (2 shared papers)Lingyuan Xu (2 shared papers)
In The Last Decade
Jifa Li
15 papers receiving 397 citations
Peers
Comparison fields: 5 of 83
- Toxicology 22
- Health Informatics 5
- Plant Science 113
- Complementary and alternative medicine 22
- Pharmacology 24
Countries citing papers authored by Jifa Li
This map shows the geographic impact of Jifa Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifa Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifa Li more than expected).
Fields of papers citing papers by Jifa Li
This network shows the impact of papers produced by Jifa Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifa Li. The network helps show where Jifa Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jifa Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 79 | |
| 2 | 2017 | 61 | |
| 3 | 2021 | 52 | |
| 4 | 2019 | 44 | |
| 5 | 2022 | 32 | |
| 6 | 2014 | 24 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2024 | 4 | |
| 15 | 2025 | 2 |
About Jifa Li
Jifa Li is a scholar working on Molecular Biology, Oncology, Plant Science, Infectious Diseases and Toxicology, having authored 15 papers that have together received 400 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Wheat and Barley Genetics and Pathology (2 papers), COVID-19 Clinical Research Studies (2 papers), Phytochemistry and biological activity of medicinal plants (2 papers), Genetics and Plant Breeding (2 papers), COVID-19 diagnosis using AI (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Toxicology (22 citations), Health Informatics (5 citations), Plant Science (113 citations), Complementary and alternative medicine (22 citations) and Pharmacology (24 citations). Jifa Li has collaborated with scholars based in China, Singapore and Iran. Frequent co-authors include Lehe Yang, Xiaoying Huang, Zhiying Deng, Jichun Tian, Youqun Xiang, Chengguang Zhao, Xuanxuan Dai, Lingyuan Xu, Guang Liang and Chengguang Zhao. Their work appears in journals such as IEEE Access, Frontiers in Pharmacology, Journal of Experimental & Clinical Cancer Research, Journal of Natural Products and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.